TagsEndocrinology 
An Update on the Role of SGLT-2 Inhibitor in the KDIGO Guideline on the Management of CKD

The Burden of Chronic Kidney Disease Chronic kidney disease (CKD) is one of the most prominent causes of death and suffering in the 21 st century. The number of patients affected by CKD has substantially increased with an estimate of 843.6 million i...

Oct 26, 2023
Nilemdo

Nilemdo ® (bempedoic acid) Daiichi Sankyo Composition: • Available as film-coated tablet containing 180 mg of bempedoic acid Indication: • As an adjunct to diet and maximally tolerated statin therapy for the treatment of adults wi...

Oct 24, 2023
Euthyrox

Euthyrox ® (levothyroxine sodium) Merck Composition: • Available as tablet containing 25, 50 or 100 µg of levothyroxine sodium Indication: • Euthyrox® 25-200 µg is indicated for the substitution therapy in hypothyroid...

Oct 24, 2023
Nustendi

Nustendi ® (bempedoic acid) Daiichi Sankyo Composition: • Available as film-coated tablet containing 180 mg of bempedoic acid and 10 mg of ezetimibe Indication: • As an adjunct to diet and maximally tolerated statin therapy for th...

Oct 24, 2023
Knowing Who and When Diabetes Education Should Best Target

Previous research has shown a relationship between weight gain around holiday seasons and seasonal variations in lifestyle behaviours and eating patterns. As glycaemic outcome is also to directly affected by the lifestyle behaviours and eating patte...

Oct 24, 2023
Exkivity

Exkivity® ( mobocertinib ) 1-3 Takeda Mobocertinib is a kinase inhibitor of the epidermal growth factor receptor (EGFR) that selectively inhibits and irreversibly binds to EGFR exon 20 insertion mutations at lower concentrations than Wild type (...

Jun 13, 2023
Kerendia

Kerendia ® ( Finerenone ) 4 Bayer Finerenone is a nonsteroidal mineralocorticoid receptor (MR) antagonist Compositio n : Available as 10mg and 20mg oral tablets Indications : Newly indicated for delaying progressive decline of kidney function ...

Jun 13, 2023
Hyperuricaemia Management in Hong Kong FAST Trial Reveals Non-inferiority

Hyperuricaemia Overview in Hong Kong Hyperuricaemia is defined as the elevated urate acid level in blood ≥ 6.8 mg/dL 2,5 . In Hong Kong, the crude prevalence of gout was 2.9% according to a population study in 2016, which was similar to the rate ...

Jun 21, 2021
Greater Risk of Hyperhomocysteinemia Associated with Age and Folate Deficiency

Hyperhomocysteinemia (HHcy) is well known to be associated with increased risk of different diseases including cardiovascular diseases, diabetes and neurodegenerative diseases. To have a better understanding of pathogenesis of HHcy and evaluate the ...

Apr 28, 2021
Association of Obesity with Poor Breast Cancer Outcome

Breast cancer is one of the life-threatening malignancies among females in Hong Kong. Obesity is recognised as being correlated with poor prognosis in several cancers, including breast cancer. A recent meta-analysis which included 27 studies had dis...

Apr 14, 2021
Make an impact on weight management with semaglutide

The prevalence of overweight and obesity has continued to grow in adults and children more than four times from 1975 to 2016 globally. A second study of an injectable anti-obesity medication, semaglutide, reported to be able to make an impact on wei...

Mar 31, 2021
Double-edged Correlation between Daytime Napping Duration and Metabolism-related Diseases

Daytime napping is a common practice in many countries which is believed to reduce sleep deficits and improve emotional status. However, a recent Chinese study has suggested that daytime napping may be detrimental to our health under certain conditi...

Mar 24, 2021